Trial intelligence / Profile preview

Nitric Oxide gas for venous stasis ulcers

NCT00613808Phase 2Terminated

Sponsor
Nitric BioTherapeutics
Start
Feb 2008
Primary completion
Nov 2008
Modality
DNA Intercalators/Alkylators, Inhalation Devices
Countries
1
01

Overview

A Phase 2 trial of nitric oxide in venous ulcer, sponsored by Nitric BioTherapeutics. Started Feb 2008; status: terminated.

02

Drugs

nitric oxide
03

Conditions

venous ulcer

Beyond the preview

Go deeper on NCT00613808.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00613808.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call